Minodronic acid
Minodronic acid (YM-529) is a third-generation bisphosphonate that directly and indirectly prevents proliferation, induces apoptosis, and inhibits metastasis of various types of cancer cells. Minodronic acid (YM-529) is an antagonist of purinergic P2X2/3 receptors involved in pain[1][2].
Product Specifications
CAS Number
180064-38-4
Product Name Alternative
YM-529
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Apoptosis; P2X Receptor
Type
Reference compound
Related Pathways
Apoptosis; Membrane Transporter/Ion Channel
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/minodronic-acid.html
Purity
99.67
Solubility
H2O : 5 mg/mL (ultrasonic; warming; adjust pH to 10 with NaOH; heat to 80°C)
Smiles
OC(P(O)(O)=O)(P(O)(O)=O)CC1=CN=C2C=CC=CN21
Molecular Formula
C9H12N2O7P2
Molecular Weight
322.15
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
P2X2 Receptor; P2X3 Receptor
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
IgA Secretory Component (SC05), CF568 conjugate, 0.1mg/mL
Cytokeratin, LMW (AE-1), CF568 conjugate, 0.1mg/mL
MCM7 (Proliferation Marker) (MCM7/1468), CF405S conjugate, 0.1mg/mL
